Synthorx: $63 Million Series C Financing

Synthorx, a developer of protein therapeutics, in its $63 million Series C financing.

Related Contacts
Ken Rollins Partner, San Diego
Asa Henin Associate, San Diego
Austin Day Associate, San Diego